Edition:
United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

39.92USD
22 Jul 2019
Change (% chg)

$0.38 (+0.96%)
Prev Close
$39.54
Open
$39.70
Day's High
$40.06
Day's Low
$39.64
Volume
347,608
Avg. Vol
319,093
52-wk High
$41.52
52-wk Low
$32.36

Bernard, Thierry 

Mr. Thierry Bernard serves as Senior Vice President Molecular Diagnostics Business Area, Member of the Executive Committee of Qiagen N.V. Thierry leads QIAGEN’s growing presence in diagnostic solutions for healthcare. Mr. Bernard joined the QIAGEN team in February 2015 from bioMerieux, where he served in roles of increasing responsibility for 15 years, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region. Prior to joining bioMérieux, he served in management roles in multiple international environments. Mr. Bernard is a member of the Boards of Directors of three privately held U.S. companies, AdvanDx, HepatoChem and more recently, Daktari Diagnostics, where he also served as CEO. He has earned degrees from Institut de Sciences Politiques de Paris or Sciences Po, Harvard Business School, London School of Economics and the College of Europe and is a member of French Foreign Trade Advisors.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --